Charles Schweizer
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 10%
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
-
- Occupational and environmental lung diseases 4
- Co-authors
- Susan C. Weil (15 shared papers)Martin D. Phillips (3 shared papers)Raffit Hassan (4 shared papers)Ira Pastan (3 shared papers)Elad Sharon (1 shared paper)Daniel A. Laheru (1 shared paper)Steven J. Cohen (1 shared paper)Ronan J. Kelly (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Clinical Cancer Research (3 papers)Journal of Pest Science (1 paper)Cytogenetic and Genome Research (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Charles Schweizer
21 papers receiving 688 citations
Peers
Comparison fields: 5 of 68
- Reproductive Medicine 141
- Oncology 300
- Pulmonary and Respiratory Medicine 206
- Immunology 141
- Biotechnology 56
Countries citing papers authored by Charles Schweizer
This map shows the geographic impact of Charles Schweizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Schweizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Schweizer more than expected).
Fields of papers citing papers by Charles Schweizer
This network shows the impact of papers produced by Charles Schweizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Schweizer. The network helps show where Charles Schweizer may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Schweizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 166 | |
| 2 | 2010 | 135 | |
| 3 | 2016 | 121 | |
| 4 | 2009 | 63 | |
| 5 | 2015 | 31 | |
| 6 | 2017 | 24 | |
| 7 | 2017 | 24 | |
| 8 | 2010 | 22 | |
| 9 | 2017 | 21 | |
| 10 | Sputum cytology of metastatic carcinoma of the lung. | 1977 | 18 |
| 11 | 2012 | 17 | |
| 12 | 2017 | 16 | |
| 13 | Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels. | 1980 | 16 |
| 14 | 2017 | 15 | |
| 15 | 2020 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2012 | 9 | |
| 18 | 2010 | 5 | |
| 19 | 1991 | 3 | |
| 20 | 2011 | 3 |
About Charles Schweizer
Charles Schweizer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Biotechnology and Molecular Biology, having authored 24 papers that have together received 738 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Occupational and environmental lung diseases (4 papers), Cancer Research and Treatments (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Glycosylation and Glycoproteins Research (2 papers), Galectins and Cancer Biology (2 papers), HER2/EGFR in Cancer Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Reproductive Medicine (141 citations), Oncology (300 citations), Pulmonary and Respiratory Medicine (206 citations), Immunology (141 citations) and Biotechnology (56 citations). Charles Schweizer has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Susan C. Weil, Martin D. Phillips, Raffit Hassan, Ira Pastan, Elad Sharon, Daniel A. Laheru, Steven J. Cohen, Ronan J. Kelly, Wenquan Wang and Daniel J. O’Shannessy. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Pest Science, Cytogenetic and Genome Research and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.